Hormone Replacement Therapy
Commons · Question 91869 · Tabled 17 Nov 2025 · Department of Health and Social Care · Official record
Answered 25 Nov 2025
Question
Asked by Freddie van Mierlo
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the recent FDA advisory committee discussion on the risks and benefits of HRT, on (a) product labelling and (b) patient information; and wheth
Answer
Answered by Zubir Ahmed, 25 Nov 2025
The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department which regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring that medicines ...